Literature DB >> 19775120

PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma.

Carolyn L Waite1, Charles M Roth.   

Abstract

Generation 5 poly(amidoamine) (PAMAM) dendrimers were modified by the addition of cyclic RGD targeting peptides and were evaluated for their ability to associate with siRNA and mediate siRNA delivery to U87 malignant glioma cells. PAMAM-RGD conjugates were able to complex with siRNA to form complexes of approximately 200 nm in size. Modest siRNA delivery was observed in U87 cells using either PAMAM or PAMAM-RGD conjugates. PAMAM-RGD conjugates prevented the adhesion of U87 cells to fibrinogen-coated plates, in a manner that depends on the number of RGD ligands per dendrimer. The delivery of siRNA through three-dimensional multicellular spheroids of U87 cells was enhanced using PAMAM-RGD conjugates compared to the native PAMAM dendrimers, presumably by interfering with integrin-ECM contacts present in a three-dimensional tumor model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19775120      PMCID: PMC3047462          DOI: 10.1021/bc900228m

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  36 in total

1.  Docking studies on alphavbeta3 integrin ligands: pharmacophore refinement and implications for drug design.

Authors:  Luciana Marinelli; Antonio Lavecchia; Kay-E Gottschalk; Ettore Novellino; Horst Kessler
Journal:  J Med Chem       Date:  2003-10-09       Impact factor: 7.446

2.  Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates.

Authors:  Rameshwer Shukla; Thommey P Thomas; Jennifer Peters; Alina Kotlyar; Andrzej Myc; James R Baker
Journal:  Chem Commun (Camb)       Date:  2005-10-10       Impact factor: 6.222

3.  PAMAM dendrimers for efficient siRNA delivery and potent gene silencing.

Authors:  Jiehua Zhou; Jiangyu Wu; Nadia Hafdi; Jean-Paul Behr; Patrick Erbacher; Ling Peng
Journal:  Chem Commun (Camb)       Date:  2006-05-10       Impact factor: 6.222

4.  Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides.

Authors:  Hyunmin Kang; Robert DeLong; Michael H Fisher; Rudolph L Juliano
Journal:  Pharm Res       Date:  2005-10-01       Impact factor: 4.200

5.  Targeting tumor angiogenic vasculature using polymer-RGD conjugates.

Authors:  Amitava Mitra; Justin Mulholland; Anjan Nan; Edwina McNeill; Hamidreza Ghandehari; Bruce R Line
Journal:  J Control Release       Date:  2005-01-20       Impact factor: 9.776

6.  Mannose/glucose-functionalized dendrimers to investigate the predictable tunability of multivalent interactions.

Authors:  Mark L Wolfenden; Mary J Cloninger
Journal:  J Am Chem Soc       Date:  2005-09-07       Impact factor: 15.419

7.  RGD conjugation to polyethyleneimine does not improve DNA delivery to bone marrow stromal cells.

Authors:  Basak Açan Clements; Jiang Bai; Cezary Kucharski; Laura-Lee Farrell; Afsaneh Lavasanifar; Bruce Ritchie; Aziz Ghahary; Hasan Uludag
Journal:  Biomacromolecules       Date:  2006-05       Impact factor: 6.988

8.  Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery.

Authors:  Mahesh L Patil; Min Zhang; Seema Betigeri; Oleh Taratula; Huixin He; Tamara Minko
Journal:  Bioconjug Chem       Date:  2008-06-25       Impact factor: 4.774

Review 9.  RNA interference in cancer.

Authors:  Andrei L Gartel; Eugene S Kandel
Journal:  Biomol Eng       Date:  2006-02-08

10.  Cell and environment interactions in tumor microregions: the multicell spheroid model.

Authors:  R M Sutherland
Journal:  Science       Date:  1988-04-08       Impact factor: 47.728

View more
  36 in total

1.  PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy.

Authors:  Fereydoon Abedi-Gaballu; Gholamreza Dehghan; Maryam Ghaffari; Reza Yekta; Soheil Abbaspour-Ravasjani; Behzad Baradaran; Jafar Ezzati Nazhad Dolatabadi; Michael R Hamblin
Journal:  Appl Mater Today       Date:  2018-05-29

2.  Efficient siRNA delivery using a polyamidoamine dendrimer with a modified pentaerythritol core.

Authors:  Yue Zhang; Chenguang Zhou; Kwang Joo Kwak; Xinmei Wang; Bryant Yung; L James Lee; Yanming Wang; Peng George Wang; Robert J Lee
Journal:  Pharm Res       Date:  2012-01-25       Impact factor: 4.200

Review 3.  Nanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides.

Authors:  Johannes Winkler
Journal:  Ther Deliv       Date:  2011-07

4.  Binding and transport of PAMAM-RGD in a tumor spheroid model: the effect of RGD targeting ligand density.

Authors:  Carolyn L Waite; Charles M Roth
Journal:  Biotechnol Bioeng       Date:  2011-07-19       Impact factor: 4.530

5.  Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review.

Authors:  Jie Liu; Warren D Gray; Michael E Davis; Ying Luo
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

6.  Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance.

Authors:  Jiayi Pan; Livia P Mendes; Momei Yao; Nina Filipczak; Sumanta Garai; Ganesh A Thakur; Can Sarisozen; Vladimir P Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2019-01-08       Impact factor: 5.571

Review 7.  Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities.

Authors:  Carolyn L Waite; Charles M Roth
Journal:  Crit Rev Biomed Eng       Date:  2012

8.  Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery.

Authors:  Swati Biswas; Pranali P Deshpande; Gemma Navarro; Namita S Dodwadkar; Vladimir P Torchilin
Journal:  Biomaterials       Date:  2012-11-05       Impact factor: 12.479

Review 9.  Development of macromolecular prodrug for rheumatoid arthritis.

Authors:  Fang Yuan; Ling-dong Quan; Liao Cui; Steven R Goldring; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

Review 10.  Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.

Authors:  Abhirup Mandal; Dhananjay Pal; Vibhuti Agrahari; Hoang My Trinh; Mary Joseph; Ashim K Mitra
Journal:  Adv Drug Deliv Rev       Date:  2018-01-13       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.